GlaxoSmithKline (GSK) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
GlaxoSmithKline (GSK) has successfully completed the sale of its remaining shares in Haleon, raising approximately £1.248 billion. With the sale of 385,320,110 shares at 324 pence each, GSK has fully exited its position in Haleon, following a series of disposals since the demerger in July 2022 that collectively generated around £3.9 billion.
For further insights into GSK stock, check out TipRanks’ Stock Analysis page.